Management Report
Management Report

6. Calculation of EBIT(DA) Before Special Items

Key performance indicators for the Bayer Group are EBIT before special items and EBITDA before special items. These indicators are reported in order to allow a more accurate assessment of business operations. The special items – comprising effects that are non-recurring or do not regularly recur or attain similar magnitudes – are detailed in the following table. EBITDA, EBITDA before special items and EBIT before special items are not defined in the International Financial Reporting Standards (IFRS) and should therefore be regarded only as supplementary information. The company considers EBITDA before special items to be a more suitable indicator of operating performance since it is not affected by depreciation, amortization, impairments or special items. By reporting this indicator, the company aims to give readers a clearer picture of the results of operations and ensure greater comparability of data over time. The EBITDA margin before special items, which is the ratio of EBITDA before special items to sales, serves as a relative indicator for the internal and external comparison of operational earning power.
Depreciation, amortization and impairments fell by 5.7% in the first half of 2011 to €1,351 million (H1 2010: €1,433 million), comprising €698 million (H1 2010: €832 million) in amortization and impairments of intangible assets and €653 million (H1 2010: €601 million) in depreciation and impairments of property, plant and equipment. Included here were impairments of €107 million (H1 2010: €143 million), of which €16 million (H1 2010: €11 million) did not constitute special items.
Special Items Reconciliation[Table 11]
 EBIT*
2nd
Quarter
2010
EBIT*
2nd
Quarter
2011
EBIT*
1st
Half
2010
EBIT*
1st
Half
2011
EBITDA**
2nd
Quarter
2010
EBITDA**
2nd
Quarter
2011
EBITDA**
1st
Half
2010
EBITDA**
1st
Half
2011
 € million€ million€ million€ million€ million€ million€ million€ million
After special items1,0111,2732,1152,4211,8001,9063,5483,772
HealthCare189512188857518688
Impairments and write-downs132-132-----
Restructuring-70-107-70-107
Litigations57-86-57-86-
Change to pension valuation parameters
-

(19)

-

(19)

-

(19)

-

(19)
CropScience66811144866666114395
Restructuring-95-306-80-215
Litigations66-11419466-114194
Change to pension valuation parameters
-

(14)

-

(14)

-

(14)

-

(14)
MaterialScience--------
Reconciliation-12-12-12-12
Restructuring-14-14-14-14
Change to pension valuation parameters
-

(2)

-

(2)

-

(2)

-

(2)
Total special items255144332586123129200495
Before special items1,2661,4172,4473,0071,9232,0353,7484,267

2010 figures restated

* EBIT = operating result as per income statement

** EBITDA = EBIT plus amortization and impairment losses on intangible assets and depreciation and impairment losses on property, plant and equipment, minus impairment loss reversals

Last updated: July 28, 2011

http://www.stockholders-newsletter-q2-2011.bayer.com/en/calculation-of-ebit-da--before-special-items.aspx

Copyright © Bayer AG

Print page

Search

Download Center

Publications

Services

Special Interest